• 1
    Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337(24): 17331745.
  • 2
    Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45(2): 507539.
  • 3
    Wong GL, Wong VW, Tan GM et al. Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis. Liver Int 2008; 28(1): 7987.
  • 4
    Wong VW, Chan SL, Mo F et al. Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers. J Clin Oncol 2010; 28(10): 16601665.
  • 5
    Yang HI, Yuen MF, Chan HL et al. Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. Lancet Oncol 2011; 12(6): 568574.
  • 6
    Gunther S, Piwon N, Will H. Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) –> T, A(1762) –> T and G(1764) –> A mutations in the core promoter. J Gen Virol 1998; 79(Pt 2): 375380.
  • 7
    Kao JH, Chen PJ, Lai MY, Chen DS. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 2003; 124(2): 327334.
  • 8
    Yuan J, Zhou B, Tanaka Y et al. Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core and their clinical implications. J Clin Virol 2007; 39(2): 8793.
  • 9
    Chou YC, Yu MW, Wu CF et al. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma. Gut 2008; 57(1): 9197.
  • 10
    Chan HL, Hui AY, Wong ML et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 2004; 53(10): 14941498.
  • 11
    Liu S, Zhang H, Gu C et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst 2009; 101(15): 10661082.
  • 12
    Takahashi K, Akahane Y, Hino K, Ohta Y, Mishiro S. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch Virol 1998; 143(12): 23132326.
  • 13
    Tangkijvanich P, Sa-Nguanmoo P, Mahachai V, Theamboonlers A, Poovorawan Y. A case-control study on sequence variations in the enhancer II/core promoter/precore and X genes of hepatitis B virus in patients with hepatocellular carcinoma. Hep Intl 2010; 4(3): 577584.
  • 14
    Yin J, Xie J, Liu S et al. Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma. Am J Gastroenterol 2011; 106(1): 8192.
  • 15
    Cho EY, Choi CS, Cho JH, Kim HC. Association between hepatitis B Virus X gene mutations and clinical status in patients with chronic hepatitis B infection. Gut Liver 2011; 5(1): 7076.
  • 16
    Tatsukawa M, Takaki A, Shiraha H et al. Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients. BMC Cancer 2011; 11: 458.
  • 17
    Jang JW, Chun JY, Park YM et al. Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma. Cancer Sci 2012; 103(2): 296304.
  • 18
    R_Development_Core_Team. A Language and Environment for Statistical Computing. In. 2.12.2 ed. Vienna, Austria: R Foundation for Statistical Computing, 2011.
  • 19
    Yotsuyanagi H, Hino K, Tomita E, Toyoda J, Yasuda K, Iino S. Precore and core promoter mutations, hepatitis B virus DNA levels and progressive liver injury in chronic hepatitis B. J Hepatol 2002; 37(3): 355363.
  • 20
    Malik A, Singhal DK, Albanyan A, Husain SA, Kar P. Hepatitis B virus gene mutations in liver diseases: a report from New Delhi. PLoS ONE 2012; 7(6): e39028.
  • 21
    Qin Y, Zhang J, Mao R et al. Prevalence of basal core promoter and precore mutations in Chinese chronic hepatitis B patients and correlation with serum HBeAG titers. J Med Virol 2009; 81(5): 807814.
  • 22
    Yang HI, Lu SN, Liaw YF et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347(3): 168174.
  • 23
    Parekh S, Zoulim F, Ahn SH et al. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol 2003; 77(12): 66016612.
  • 24
    Chan HL, Tse CH, Mo F et al. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma. J Clin Oncol 2008; 26(2): 177182.